# AnalyST & Brugada Syndrome - Feasibility Study

> **NCT02052765** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 16 (actual)

## Conditions studied

- Brugada Syndrome

## Interventions

- **DEVICE:** ECG continuous recording (Analyze ST)

## Key facts

- **NCT ID:** NCT02052765
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052765, "AnalyST & Brugada Syndrome - Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02052765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*